Targeting ALDH as a potential approach for cancer cell labeling might be an appropriate “tracer” for discerning drug-sensitive and drug-resistant phenotypes of cancers to evaluate the effectiveness of novel therapies (27). The gene discussed is LDHA; the disease is cancer.